8-hydroxy quinoline derivatives
US9302993B2 · kind B2 · utility
0Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2014 |
| Grant date | Apr 5, 2016 |
| Priority date | — |
| Expiry date | Oct 9, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes a method for the treatment of a neurological condition in a subject which comprises administering to a subject in need thereof a therapeutically effect amount of a compound of the formulaor pharmaceutically acceptable salts, hydrates, or solvates thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.